Contact us for more information or to book your assessment visit!

Find the specialized Gondola® Partner Center nearest you and book an appointment to assess your treatment response.

I am a*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
How it works

Gondola AMPS therapy
for medical professionals

Gondola AMPS therapy for medical professionals

AMPS therapy improves your patients' walking impairments

With a neurological disorder such as a  neurodegenerative disease (e.g., Parkinson’s disease), brain lesion (e.g., stroke) or chronic neurological condition (e.g., cerebral palsy), walking requires compensatory strategies to overcome the disability. These new walking compensations are demanding and increase the need for cognitive control. On the contrary, a healthy walking pattern is predominantly driven by automatic patterns with minimal cognitive control. 
One way to enhance the automatic circuits and reduce cognitive control is through the somatosensory pathway. Somatosensory afferences are known to be essential for body representation and walking control. Specifically, somatosensory stimulation of the soles of the feet can improve walking and balance performance 1–4 and lead to plasticity in the central nervous system.

Gondola AMPS a innovative sensorymotor therapy
Gondola AMPS a innovative sensorymotor therapy
The therapy

Non-invasive
somatosensory
stimulation therapy

Gondola Medical Technologies has developed a novel non-invasive somatosensory stimulation therapy based on mechanical pressure pulses. The pulses are applied in two specific areas of both feet, the head of the big toe and the first metatarsal joint. The therapy comprises of four repetitions of a stimulation cycle that lasts 24
seconds, resulting in an overall therapy time of only 96
seconds.
The stimulation cycles each consist of a six-second stimulation of the four specific target areas. This
approach is termed the Gondola “Automated Mechanical Peripheral Stimulation” (AMPS) therapy.
Somatosensory inputs (pressure and tactile inputs) are integrated and processed by the central nervous system, leading to a synaptic reinforcement within the sensory-motor system and improved walking and balance functions.

Read Less Read More
Gondola AMPS a innovative sensorymotor therapy
The outcomes

Learn more about the benefits of Gondola amps therapy

Parkinson

Clinical Evidence

Parkinsonian
Gait

Parkinsonian Gait

Characterized by slowness, short steps, reduced angular kinematics range of motion and/or asymmetries in gait.
Read more

Reduced
Risk of Falling

Reduced
Risk of Falling

Improved balance and better control of walking abilities reduce the falling risk of Parkinson's through regular use of Gondola AMPS.
Read more

Enhanced
Dual-Tasking

Enhanced
Dual-Tasking

Regular use of Gondola AMPS allows patients to improve their ability to conduct two tasks at the same time e.g., walk and talk
Read more

Parkinson

Other Evidence

Brain
Activation

Brain Activation

Increased functional connectivity in brain areas involved in walking and balance function.
Read more

Cardiovascular

Cardiovascular

Gondola AMPS therapy has also shown improvements in cardiovascular modulation.
Read more

Clinically
proven

Clinically proven

Gondola AMPS efficacy has been proved using many clinical tests: as UPDRS III, and PDQ39.
Read more
Backed-by-science

Therapy efficacy proofed in clinical research studies

The efficacy of AMPS therapy administered through the Gondola® medical device has been established in 12 clinical research studies comprising a population of more than 250 patients diagnosed with Parkinson's disease. Results of these studies indicate a significant improvement in the gait parameters of the patients, including enhanced speed, stride length, gait symmetry, and turning ability, following AMPS therapy. Interestingly, the beneficial effects were apparent after a single AMPS therapy session and could remain up to four days afterward.

Read the publications
Read More
Gondola AMPS efficacy has been documented by several studies
Gondola AMPS efficacy has been documented by several studies
Gondola AMPS efficacy has been documented by several studies
Backed-by-science

Mechanism of Action

How the Gondola AMPS impacts on brain improving walking impairments

The mechanism believed to be associated with AMPS is an induced synaptic plasticity with strengthening of the neural circuits involved in walking automaticity. This hypothesis is supported by the clinical outcomes, the discovery of increased connectivity between brain regions involved in walking control, and an increase in brain-derived neurotrophic factor (BDNF) after AMPS.